Shared on27 Aug 25Fair value Increased 2.03%
Analysts raised Altria Group’s price target to $62.88, citing its increased dividend, improving regulatory outlook, and sustained earnings through pricing power, while some concerns remain over structural industry headwinds and growth limitations. Analyst Commentary Altria’s recent dividend increase and consistent track record of annual dividend growth support confidence in its capital return program.
Shared on07 Aug 25Fair value Increased 5.27%
Despite ongoing structural headwinds, a demanding valuation relative to peers, muted global nicotine growth prospects, and continued analyst preference for British American, the consensus analyst price target for Altria Group has been revised upward from $58.54 to $61.62. Analyst Commentary Structural headwinds impacting Altria's business outlook.
Shared on23 Apr 25Fair value Decreased 0.14%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25Fair value Increased 0.41%
AnalystConsensusTarget has increased revenue growth from -0.3% to -0.3%.
Shared on02 Apr 25Fair value Decreased 0.018%
AnalystConsensusTarget has decreased revenue growth from -0.1% to -0.2%.
Shared on26 Mar 25Fair value Decreased 0.14%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 0.53%
AnalystConsensusTarget has decreased revenue growth from 0.1% to -0.1%.
Shared on10 Mar 25Fair value Decreased 3.15%
AnalystConsensusTarget has decreased revenue growth from 1.0% to 0.1%.